2 Trademark Results found for "COSCIENS"

Also try searching for:

COSCIENS*

COSC*

*ENS

CO*NS

Mark	Details	Status	Class/Description
	COSCIENS COSCIENS Biopharma Inc. UK00004139189	Registered	Toiletry preparations; animal and pet care products, namely, animal hu... Class 003 Class 003 Cosmetics and Cleaning Products Toiletry preparations; animal and pet care products, namely, animal humectant, namely, moisturizers and conditioners, animal shampoo; oat based cosmetic products for animals, namely, animal skin creams and balms; cosmetics; cosmetics, namely, shampoo, anti-irritant creams, moisturizing creams, skin creams, skin balms, oat based cosmetic products, namely, skin moisturizing products in the form of creams, gels and lotions; sunblock and sunscreen lotions, eye shadow and blush powders, lip sticks and balms; avenanthramides and oat beta glucan for use as ingredients in cosmetics. Class 005 Class 005 Pharmaceutical Products Nutritional supplements, cosmeceuticals, nutraceuticals and pharmaceuticals; dietetic food and substances adapted for medical or veterinary use; dietary and nutritional supplements for improving nail strength, supporting healthy skin and maintaining shiny hair; dietary and nutritional supplements for general health and wellbeing; nutritional supplements, cosmeceuticals, nutraceuticals and pharmaceuticals, containing avenanthramides; nutritional supplements, cosmeceuticals, nutraceuticals and pharmaceuticals, containing oat beta glucan; veterinary medicine products, namely, natural (non-antibiotic) anti-microbial preparations for the treatment of mastitis in animals; natural saponin-based preparations acting on the immune systems of animals and humans to help fight infection and disease; pharmaceutical medicine products for human and animal use, namely pharmaceutical preparations in the area of immunology and bioengineering, oat based preparations for use in the diagnosis and monitoring of diabetes, pharmaceutical preparations in cream, lotion and liquid gel forms for the moisturizing treatment of lips and skin and the anti-bacterial treatment of cold sores, herpes sores, acne and skin diseases, pharmaceutical anti-irritant and moisturizing cream, immune system stimulants; pharmaceutical preparations for skin care, namely medicated sunscreens, medicated skin creams, gels, balms and lotions, medicated shampoo, medicated lip balm; health care products, namely anti-irritant and moisturizing cream, shampoo; nutritional additives for animal feed, nutritional supplements, namely oat based supplements; additives to fodder for medical purposes; pharmaceutical preparations in the areas of nutrition and immunology; pharmaceuticals preparation for immunology and inflammation based diseases; avenanthramides and oat beta glucan for use as ingredients in nutritional supplements, cosmeceuticals, nutraceuticals, and pharmaceuticals; pharmaceutical preparations used for the treatment of cancer; pharmaceutical preparations administered as a radiosensitizer and used for the treatment of cancer; pharmaceutical preparations used for the treatment of urological diseases; pharmaceutical preparations used for the treatment of hormonal disorders; synthetic peptides-containing pharmaceutical preparations used for hormonal and tumors treatments; pharmaceutical preparations used for the treatment of endocrine diseases; pharmaceutical preparations used for the treatment of carcinoid tumors; pharmaceutical preparations used for the treatment of haematological diseases; pharmaceutical preparations used for the treatment of age-related diseases; pharmaceutical preparations used for the treatment of ophthalmological disorders; pharmaceutical preparations used for the treatment of reproductive system disorders; pharmaceutical preparations used for the treatment of endometriosis; pharmaceutical preparations used for the treatment of uterine myoma; pharmaceutical preparations used for the treatment of non-malignant tumors; pharmaceutical preparations used for the treatment of benign prostatic hyperplasia; pharmaceutical preparations used for the treatment of tropical diseases; pharmaceutical preparations used for the treatment of infectious disease; pharmaceutical preparations used for the treatment of leishmaniasis; pharmaceutical preparations used for the treatment of obesity; pharmaceutical preparations used for the treatment of diabetes and disorders related to diabetes; pharmaceutical preparations containing cytotoxic products, conjugated or not, for the treatment of cancer or infectious diseases; pharmaceutical preparations used as a tubulin inhibitor for the treatment of cancer; pharmaceutical preparations based on LHRH antagonists platform for the treatment of cancer, hormonal tumors, or hormonal disorders; pharmaceutical preparations based on bombesin antagonist platform for the treatment of cancer; pharmaceutical preparations based on inhibitors of the Akt pathway for the treatment of cancer or infectious diseases; pharmaceutical preparations based on angiogenesis inhibitors platform for the treatment of cancer; pharmaceutical preparations used to induce apoptosis; pharmaceutical preparations used to stimulate growth hormone secretagogue; vaccines for the treatment of tumors; pharmaceutical preparations for the treatment of cardiovascular diseases; pharmaceutical preparations for the treatment of respiratory diseases; pharmaceutical preparations for the treatment of gastrointestinal diseases; diagnostic agents, preparations and substances for medical purposes; pharmaceutical products, comprising growth hormone secretagogues, ghrelin receptor agonists, ghrelin receptor antagonists, ghrelin mimetics, growth hormone analogues, growth hormone fusion proteins, growth hormone releasing hormone analogues, auto immune modulating proteins, therapeutic antibodies, small molecule kinase inhibitors, phospholipids for the treatment of neurological disorders; pharmaceutical preparations for the treatment of nasopharyngeal disorders; antibiotics; antibacterial and fungicidal preparations; pharmaceutical preparations for the treatment of mental health; pharmaceutical preparations for the treatment of autoimmune diseases; pharmaceutical preparations for the treatment of rheumatoid diseases; pharmaceutical preparations for contraceptives and women's health; analgesic pharmaceutical products, comprising small molecule kinase inhibitors, phospholipids, therapeutic antibodies, natural products; sedativa and pharmaceutical preparations for the treatment of psychiatric disorders; pharmaceutical preparations for the treatment of pain; pharmaceutical preparations for palliative treatments; pharmaceutical preparations for the treatment of addictions; pharmaceutical formulations for the treatment of paediatric indications. ... Class 030 Staple Food Products Bread; flour and preparations made from cereals; oat based food products, namely, oat bran, oat flour, oat starch, oat beta glucan, noodles and medicinal oils. Class 032 Light Beverage Products Non-alcoholic beverages; preparations for making non-alcoholic beverages; beverages, namely, non alcoholic fibre health beverages for human and animal use.
	COSCIENS BIOPHARMA COSCIENS Biopharma Inc. UK00004139199	Registered	Toiletry preparations; Animal and pet care products, namely, animal hu... Class 003 Class 003 Cosmetics and Cleaning Products Toiletry preparations; Animal and pet care products, namely, animal humectant, namely, moisturizers and conditioners, animal shampoo; oat based cosmetic products for animals, namely, animal skin creams and balms; cosmetics; cosmetics, namely, shampoo, anti-irritant creams, moisturizing creams, skin creams, skin balms, oat based cosmetic products, namely, skin moisturizing products in the form of creams, gels and lotions; sunblock and sunscreen lotions, eye shadow and blush powders, lip sticks and balms; avenanthramides and oat beta glucan for use as ingredients in cosmetics. Class 005 Class 005 Pharmaceutical Products Nutritional supplements, cosmeceuticals, nutraceuticals and pharmaceuticals; dietetic food and substances adapted for medical or veterinary use; dietary and nutritional supplements for improving nail strength, supporting healthy skin and maintaining shiny hair; dietary and nutritional supplements for general health and wellbeing; nutritional supplements, cosmeceuticals, nutraceuticals and pharmaceuticals, containing avenanthramides; nutritional supplements, cosmeceuticals, nutraceuticals and pharmaceuticals, containing oat beta glucan; veterinary medicine products, namely, natural (non-antibiotic) anti-microbial preparations for the treatment of mastitis in animals; natural saponin-based preparations acting on the immune systems of animals and humans to help fight infection and disease; pharmaceutical medicine products for human and animal use, namely pharmaceutical preparations in the area of immunology and bioengineering, oat based preparations for use in the diagnosis and monitoring of diabetes, pharmaceutical preparations in cream, lotion and liquid gel forms for the moisturizing treatment of lips and skin and the anti-bacterial treatment of cold sores, herpes sores, acne and skin diseases, pharmaceutical anti-irritant and moisturizing cream, immune system stimulants; pharmaceutical preparations for skin care, namely medicated sunscreens, medicated skin creams, gels, balms and lotions, medicated shampoo, medicated lip balm; health care products, namely anti-irritant and moisturizing cream, shampoo; nutritional additives for animal feed, nutritional supplements, namely oat based supplements; additives to fodder for medical purposes; pharmaceutical preparations in the areas of nutrition and immunology; pharmaceuticals preparation for immunology and inflammation based diseases; avenanthramides and oat beta glucan for use as ingredients in nutritional supplements, cosmeceuticals, nutraceuticals, and pharmaceuticals; pharmaceutical preparations used for the treatment of cancer; pharmaceutical preparations administered as a radiosensitizer and used for the treatment of cancer; pharmaceutical preparations used for the treatment of urological diseases; pharmaceutical preparations used for the treatment of hormonal disorders; synthetic peptides-containing pharmaceutical preparations used for hormonal and tumors treatments; pharmaceutical preparations used for the treatment of endocrine diseases; pharmaceutical preparations used for the treatment of carcinoid tumors; pharmaceutical preparations used for the treatment of haematological diseases; pharmaceutical preparations used for the treatment of age-related diseases; pharmaceutical preparations used for the treatment of ophthalmological disorders; pharmaceutical preparations used for the treatment of reproductive system disorders; pharmaceutical preparations used for the treatment of endometriosis; pharmaceutical preparations used for the treatment of uterine myoma; pharmaceutical preparations used for the treatment of non-malignant tumors; pharmaceutical preparations used for the treatment of benign prostatic hyperplasia; pharmaceutical preparations used for the treatment of tropical diseases; pharmaceutical preparations used for the treatment of infectious disease; pharmaceutical preparations used for the treatment of leishmaniasis; pharmaceutical preparations used for the treatment of obesity; pharmaceutical preparations used for the treatment of diabetes and disorders related to diabetes; pharmaceutical preparations containing cytotoxic products, conjugated or not, for the treatment of cancer or infectious diseases; pharmaceutical preparations used as a tubulin inhibitor for the treatment of cancer; pharmaceutical preparations based on LHRH antagonists platform for the treatment of cancer, hormonal tumors, or hormonal disorders; pharmaceutical preparations based on bombesin antagonist platform for the treatment of cancer; pharmaceutical preparations based on inhibitors of the Akt pathway for the treatment of cancer or infectious diseases; pharmaceutical preparations based on angiogenesis inhibitors platform for the treatment of cancer; pharmaceutical preparations used to induce apoptosis; pharmaceutical preparations used to stimulate growth hormone secretagogue; vaccines for the treatment of tumors; pharmaceutical preparations for the treatment of cardiovascular diseases; pharmaceutical preparations for the treatment of respiratory diseases; pharmaceutical preparations for the treatment of gastrointestinal diseases; diagnostic agents, preparations and substances for medical purposes; pharmaceutical products, comprising growth hormone secretagogues, ghrelin receptor agonists, ghrelin receptor antagonists, ghrelin mimetics, growth hormone analogues, growth hormone fusion proteins, growth hormone releasing hormone analogues, auto immune modulating proteins, therapeutic antibodies, small molecule kinase inhibitors, phospholipids for the treatment of neurological disorders; pharmaceutical preparations for the treatment of nasopharyngeal disorders; antibiotics; antibacterial and fungicidal preparations; pharmaceutical preparations for the treatment of mental health; pharmaceutical preparations for the treatment of autoimmune diseases; pharmaceutical preparations for the treatment of rheumatoid diseases; pharmaceutical preparations for contraceptives and women's health; analgesic pharmaceutical products, comprising small molecule kinase inhibitors, phospholipids, therapeutic antibodies, natural products; sedativa and pharmaceutical preparations for the treatment of psychiatric disorders; pharmaceutical preparations for the treatment of pain; pharmaceutical preparations for palliative treatments; pharmaceutical preparations for the treatment of addictions; pharmaceutical formulations for the treatment of paediatric indications. ... Class 030 Staple Food Products Bread; flour and preparations made from cereals; oat based food products, namely, oat bran, oat flour, oat starch, oat beta glucan, noodles and medicinal oils. Class 032 Light Beverage Products Non-alcoholic beverages; preparations for making non-alcoholic beverages; beverages, namely, non alcoholic fibre health beverages for human and animal use.

Registered

COSCIENS

COSCIENS Biopharma Inc.

003

005

Class 005

Pharmaceutical Products

Nutritional supplements, cosmeceuticals, nutraceuticals and pharmaceuticals; dietetic food and substances adapted for medical or veterinary use; dietary and nutritional supplements for improving nail strength, supporting healthy skin and maintaining shiny hair; dietary and nutritional supplements for general health and wellbeing; nutritional supplements, cosmeceuticals, nutraceuticals and pharmaceuticals, containing avenanthramides; nutritional supplements, cosmeceuticals, nutraceuticals and pharmaceuticals, containing oat beta glucan; veterinary medicine products, namely, natural (non-antibiotic) anti-microbial preparations for the treatment of mastitis in animals; natural saponin-based preparations acting on the immune systems of animals and humans to help fight infection and disease; pharmaceutical medicine products for human and animal use, namely pharmaceutical preparations in the area of immunology and bioengineering, oat based preparations for use in the diagnosis and monitoring of diabetes, pharmaceutical preparations in cream, lotion and liquid gel forms for the moisturizing treatment of lips and skin and the anti-bacterial treatment of cold sores, herpes sores, acne and skin diseases, pharmaceutical anti-irritant and moisturizing cream, immune system stimulants; pharmaceutical preparations for skin care, namely medicated sunscreens, medicated skin creams, gels, balms and lotions, medicated shampoo, medicated lip balm; health care products, namely anti-irritant and moisturizing cream, shampoo; nutritional additives for animal feed, nutritional supplements, namely oat based supplements; additives to fodder for medical purposes; pharmaceutical preparations in the areas of nutrition and immunology; pharmaceuticals preparation for immunology and inflammation based diseases; avenanthramides and oat beta glucan for use as ingredients in nutritional supplements, cosmeceuticals, nutraceuticals, and pharmaceuticals; pharmaceutical preparations used for the treatment of cancer; pharmaceutical preparations administered as a radiosensitizer and used for the treatment of cancer; pharmaceutical preparations used for the treatment of urological diseases; pharmaceutical preparations used for the treatment of hormonal disorders; synthetic peptides-containing pharmaceutical preparations used for hormonal and tumors treatments; pharmaceutical preparations used for the treatment of endocrine diseases; pharmaceutical preparations used for the treatment of carcinoid tumors; pharmaceutical preparations used for the treatment of haematological diseases; pharmaceutical preparations used for the treatment of age-related diseases; pharmaceutical preparations used for the treatment of ophthalmological disorders; pharmaceutical preparations used for the treatment of reproductive system disorders; pharmaceutical preparations used for the treatment of endometriosis; pharmaceutical preparations used for the treatment of uterine myoma; pharmaceutical preparations used for the treatment of non-malignant tumors; pharmaceutical preparations used for the treatment of benign prostatic hyperplasia; pharmaceutical preparations used for the treatment of tropical diseases; pharmaceutical preparations used for the treatment of infectious disease; pharmaceutical preparations used for the treatment of leishmaniasis; pharmaceutical preparations used for the treatment of obesity; pharmaceutical preparations used for the treatment of diabetes and disorders related to diabetes; pharmaceutical preparations containing cytotoxic products, conjugated or not, for the treatment of cancer or infectious diseases; pharmaceutical preparations used as a tubulin inhibitor for the treatment of cancer; pharmaceutical preparations based on LHRH antagonists platform for the treatment of cancer, hormonal tumors, or hormonal disorders; pharmaceutical preparations based on bombesin antagonist platform for the treatment of cancer; pharmaceutical preparations based on inhibitors of the Akt pathway for the treatment of cancer or infectious diseases; pharmaceutical preparations based on angiogenesis inhibitors platform for the treatment of cancer; pharmaceutical preparations used to induce apoptosis; pharmaceutical preparations used to stimulate growth hormone secretagogue; vaccines for the treatment of tumors; pharmaceutical preparations for the treatment of cardiovascular diseases; pharmaceutical preparations for the treatment of respiratory diseases; pharmaceutical preparations for the treatment of gastrointestinal diseases; diagnostic agents, preparations and substances for medical purposes; pharmaceutical products, comprising growth hormone secretagogues, ghrelin receptor agonists, ghrelin receptor antagonists, ghrelin mimetics, growth hormone analogues, growth hormone fusion proteins, growth hormone releasing hormone analogues, auto immune modulating proteins, therapeutic antibodies, small molecule kinase inhibitors, phospholipids for the treatment of neurological disorders; pharmaceutical preparations for the treatment of nasopharyngeal disorders; antibiotics; antibacterial and fungicidal preparations; pharmaceutical preparations for the treatment of mental health; pharmaceutical preparations for the treatment of autoimmune diseases; pharmaceutical preparations for the treatment of rheumatoid diseases; pharmaceutical preparations for contraceptives and women's health; analgesic pharmaceutical products, comprising small molecule kinase inhibitors, phospholipids, therapeutic antibodies, natural products; sedativa and pharmaceutical preparations for the treatment of psychiatric disorders; pharmaceutical preparations for the treatment of pain; pharmaceutical preparations for palliative treatments; pharmaceutical preparations for the treatment of addictions; pharmaceutical formulations for the treatment of paediatric indications.

...

Toiletry preparations; animal and pet care products, namely, animal hu...

Registered

COSCIENS BIOPHARMA

COSCIENS Biopharma Inc.

003

005

Class 005

Pharmaceutical Products

...

Toiletry preparations; Animal and pet care products, namely, animal hu...

Owners

Cosciens biopharma inc. (2)

Categories

Class 3 (2)

Class 5 (2)

Class 30 (2)

Class 32 (2)

Attorney

Keystone law (2)

Correspondents

48 chancery lane (2)

Display

List View

Grid View

Apply for Trade Mark

Select countries to protect your logo Trade Mark

Trade Mark Name

Country Selected

United Kingdom

£249/ 1 class + gov fee

United States

£74/ 1 class + gov fee

Canada

£297/ 1 class + gov fee

Mexico

£371/ 1 class + gov fee

European Union

£521/ 1 class + gov fee

China

£371/ 1 class + gov fee

South Korea

£520/ 1 class + gov fee

Japan

£594/ 1 class + gov fee

India

£186/ 1 class + gov fee

United Kingdom

£249/ 1 class + gov fee

Australia

£223/ 1 class + gov fee

Israel

£520/ 1 class + gov fee

United Arab Emirates

£520/ 1 class + gov fee

New Zealand

£297/ 1 class + gov fee

Brazil

£371/ 1 class + gov fee

Taiwan

£594/ 1 class + gov fee

Ukraine

£594/ 1 class + gov fee

Indonesia

£520/ 1 class + gov fee

South Africa

£371/ 1 class + gov fee

Singapore

£594/ 1 class + gov fee

Saudi Arabia

£594/ 1 class + gov fee

Afghanistan

£594/ 1 class + gov fee

Algeria

£594/ 1 class + gov fee

Argentina

£297/ 1 class + gov fee

Austria

£669/ 1 class + gov fee

Bahrain

£520/ 1 class + gov fee

Bangladesh

£446/ 1 class + gov fee

Benelux

£743/ 1 class + gov fee

Bhutan

£669/ 1 class + gov fee

Bolivia

£594/ 1 class + gov fee

Botswana

£966/ 1 class + gov fee

British Virgin Islands

£891/ 1 class + gov fee

Bulgaria

£594/ 1 class + gov fee

Cambodia

£594/ 1 class + gov fee

Chile

£371/ 1 class + gov fee

Colombia

£520/ 1 class + gov fee

Congo

£891/ 1 class + gov fee

Costa Rica

£669/ 1 class + gov fee

Croatia

£669/ 1 class + gov fee

Cyprus

£743/ 1 class + gov fee

Czech Republic

£669/ 1 class + gov fee

Denmark

£594/ 1 class + gov fee

Aruba

£891/ 1 class + gov fee

Dominican Republic

£669/ 1 class + gov fee

Curacao

£891/ 1 class + gov fee

Macau

£520/ 1 class + gov fee

Greenland

£594/ 1 class + gov fee

Ecuador

£594/ 1 class + gov fee

Egypt

£520/ 1 class + gov fee

El Salvador

£594/ 1 class + gov fee

Ethiopia

£817/ 1 class + gov fee

France

£669/ 1 class + gov fee

Gaza

£594/ 1 class + gov fee

Germany

£669/ 1 class + gov fee

Greece

£594/ 1 class + gov fee

Guatemala

£669/ 1 class + gov fee

Haiti

£669/ 1 class + gov fee

Honduras

£669/ 1 class + gov fee

Hong Kong (SAR)

£669/ 1 class + gov fee

Hungary

£817/ 1 class + gov fee

Iraq

£1,114/ 1 class + gov fee

Italy

£669/ 1 class + gov fee

Jordan

£594/ 1 class + gov fee

Kazakhstan

£594/ 1 class + gov fee

Kenya

£669/ 1 class + gov fee

Kuwait

£594/ 1 class + gov fee

Laos

£520/ 1 class + gov fee

Lebanon

£743/ 1 class + gov fee

Lesotho

£891/ 1 class + gov fee

Libya

£669/ 1 class + gov fee

Madrid Protocol (WIPO)

£1,486/ 1 class + gov fee

Malawi

£817/ 1 class + gov fee

Malaysia

£520/ 1 class + gov fee

Maldives

£743/ 1 class + gov fee

Morocco

£743/ 1 class + gov fee

Mozambique

£669/ 1 class + gov fee

Myanmar

£594/ 1 class + gov fee

Namibia

£594/ 1 class + gov fee

Nepal

£520/ 1 class + gov fee

Nicaragua

£669/ 1 class + gov fee

Norway

£669/ 1 class + gov fee

Oman

£817/ 1 class + gov fee

Pakistan

£594/ 1 class + gov fee

Panama

£669/ 1 class + gov fee

Paraguay

£669/ 1 class + gov fee

Peru

£594/ 1 class + gov fee

Philippines

£669/ 1 class + gov fee

Poland

£371/ 1 class + gov fee

Portugal

£669/ 1 class + gov fee

Puerto Rico

£669/ 1 class + gov fee

Qatar

£594/ 1 class + gov fee

Romania

£669/ 1 class + gov fee

Serbia

£669/ 1 class + gov fee

Slovakia

£669/ 1 class + gov fee

Spain

£669/ 1 class + gov fee

Sri Lanka

£520/ 1 class + gov fee

Swaziland

£966/ 1 class + gov fee

Sweden

£594/ 1 class + gov fee

Switzerland

£669/ 1 class + gov fee

Thailand

£594/ 1 class + gov fee

Tunisia

£669/ 1 class + gov fee

Turkey

£594/ 1 class + gov fee

Uganda

£520/ 1 class + gov fee

United Republic of Tanzania

£520/ 1 class + gov fee

Uruguay

£594/ 1 class + gov fee

Venezuela

£669/ 1 class + gov fee

Vietnam

£594/ 1 class + gov fee

West Bank, Palestine

£594/ 1 class + gov fee

Yemen

£1,263/ 1 class + gov fee

Albania

£669/ 1 class + gov fee

Andorra

£669/ 1 class + gov fee

Angola

£966/ 1 class + gov fee

Antigua and Barbuda

£891/ 1 class + gov fee

Armenia

£594/ 1 class + gov fee

Azerbaijan

£594/ 1 class + gov fee

Bahamas

£1,040/ 1 class + gov fee

Barbados

£966/ 1 class + gov fee

Belgium

£743/ 1 class + gov fee

Belize

£966/ 1 class + gov fee

Benin

£594/ 1 class + gov fee

Bosnia and Herzegovina

£743/ 1 class + gov fee

Brunei

£966/ 1 class + gov fee

Burkina Faso

£594/ 1 class + gov fee

Burundi

£891/ 1 class + gov fee

Cabo Verde

£669/ 1 class + gov fee

Cameroon

£594/ 1 class + gov fee

Central African Republic (CAR)

£594/ 1 class + gov fee

Chad

£594/ 1 class + gov fee

Comoros

£594/ 1 class + gov fee

Cote d'Ivoire

£594/ 1 class + gov fee

Czechia

£743/ 1 class + gov fee

Djibouti

£891/ 1 class + gov fee

Dominica

£966/ 1 class + gov fee

Equatorial Guinea

£594/ 1 class + gov fee

Eritrea

£743/ 1 class + gov fee

Estonia

£966/ 1 class + gov fee

Eswatini

£966/ 1 class + gov fee

Fiji

£669/ 1 class + gov fee

Finland

£520/ 1 class + gov fee

Gabon

£594/ 1 class + gov fee

Gambia

£669/ 1 class + gov fee

Georgia

£594/ 1 class + gov fee

Ghana

£743/ 1 class + gov fee

Grenada

£966/ 1 class + gov fee

Guinea

£594/ 1 class + gov fee

Guinea-Bissau

£594/ 1 class + gov fee

Guyana

£966/ 1 class + gov fee

Iceland

£966/ 1 class + gov fee

Ireland

£594/ 1 class + gov fee

Jamaica

£891/ 1 class + gov fee

Kiribati

£743/ 1 class + gov fee

Kosovo

£669/ 1 class + gov fee

Kyrgyzstan

£669/ 1 class + gov fee

Latvia

£520/ 1 class + gov fee

Liberia

£743/ 1 class + gov fee

Liechtenstein

£743/ 1 class + gov fee

Lithuania

£520/ 1 class + gov fee

Luxembourg

£743/ 1 class + gov fee

Madagascar

£743/ 1 class + gov fee

Mali

£594/ 1 class + gov fee

Malta

£446/ 1 class + gov fee

Marshall Islands

£743/ 1 class + gov fee

Mauritania

£594/ 1 class + gov fee

Mauritius

£743/ 1 class + gov fee

Micronesia

£743/ 1 class + gov fee

Moldova

£743/ 1 class + gov fee

Monaco

£1,040/ 1 class + gov fee

Mongolia

£446/ 1 class + gov fee

Montenegro

£669/ 1 class + gov fee

Nauru

£743/ 1 class + gov fee

Netherlands

£743/ 1 class + gov fee

Niger

£594/ 1 class + gov fee

Nigeria

£297/ 1 class + gov fee

North Macedonia

£669/ 1 class + gov fee

Palau

£743/ 1 class + gov fee

Palestine

£743/ 1 class + gov fee

Papua New Guinea

£594/ 1 class + gov fee

Rwanda

£743/ 1 class + gov fee

Saint Kitts and Nevis

£966/ 1 class + gov fee

Saint Lucia

£966/ 1 class + gov fee

Saint Vincent and the Grenadines

£966/ 1 class + gov fee

Samoa

£891/ 1 class + gov fee

San Marino

£743/ 1 class + gov fee

Sao Tome and Principe

£743/ 1 class + gov fee

Senegal

£594/ 1 class + gov fee

Seychelles

£743/ 1 class + gov fee

Sierra Leone

£743/ 1 class + gov fee

Slovenia

£669/ 1 class + gov fee

Solomon Islands

£743/ 1 class + gov fee

Somalia

£743/ 1 class + gov fee

South Sudan

£743/ 1 class + gov fee

Suriname

£1,189/ 1 class + gov fee

Tajikistan

£594/ 1 class + gov fee

Tanzania

£520/ 1 class + gov fee

Timor-Leste

£743/ 1 class + gov fee

Togo

£594/ 1 class + gov fee

Tonga

£966/ 1 class + gov fee

Trinidad and Tobago

£891/ 1 class + gov fee

Turkmenistan

£594/ 1 class + gov fee

Tuvalu

£743/ 1 class + gov fee

Uzbekistan

£520/ 1 class + gov fee

Vanuatu

£891/ 1 class + gov fee

Zambia

£669/ 1 class + gov fee

Zimbabwe

£669/ 1 class + gov fee

OAPI

£669/ 1 class + gov fee

ARIPO

£743/ 1 class + gov fee

End of search results

Page 1 of 1